Perivascular adipose tissue as a messenger of the brain-vessel axis: Role in vascular inflammation and dysfunction

Journal of Physiology and Pharmacology

Volumn 58, Issue 4, 2007, Pages 591-610

  Guzik, T J ^a,b   Marvar, P J ^b   Czesnikiewicz Guzik, M ^a,b   Korbut, R ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Central nervous system; Cytokines; Immune regulation; Inflammation; Nitric oxide; Perivascular adipose tissue; Superoxide

Indexed keywords

ACEBUTOLOL; ADIPOCYTOKINE; ADIPONECTIN; ANGIOTENSIN II; CHEMOKINE; INTERLEUKIN 6; LEPTIN; NITRIC OXIDE; PROTEIN ADRF; RANTES; RESISTIN; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT;

ADIPOSE TISSUE; ADRENERGIC SYSTEM; BRAIN BLOOD VESSEL; BRAIN DEPTH STIMULATION; BRAIN DYSFUNCTION; BRAIN FUNCTION; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; DIABETES MELLITUS; ENCEPHALITIS; GENE CONTROL; HUMAN; HYPERTENSION; IMMUNE SYSTEM; MACROPHAGE; MUSCLE CONTRACTILITY; NONHUMAN; OBESITY; REVIEW; RISK FACTOR; T LYMPHOCYTE; VASCULAR TISSUE;

ADIPOCYTES; ADIPOSE TISSUE; BRAIN; CYTOKINES; HUMANS; INFLAMMATION; VASCULAR DISEASES;

EID: 38149036625     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Gollasch M, Dubrovska G. Paracrine Role for Periadventitial Adipose Tissue in the Regulation of Arterial Tone. Trends Pharmacol Sci 2004; 25: 647-653.
2. Gao YJ. Dual Modulation of Vascular Function by Perivascular Adipose Tissue and Its Potential Correlation with Adiposity/Lipoatrophy-Related Vascular Dysfunction. Curr Pharm Des 2007; 13: 2185-2192.
3. Galvez B, de Castro J, Herold D, et al. Perivascular Adipose Tissue and Mesenteric Vascular Function in Spontaneously Hypertensive Rats. Arterioscler Thromb Vasc Biol 2006; 26: 1297-1302.
4. Soltis EE, Cassis LA. Influence of Perivascular Adipose Tissue on Rat Aortic Smooth Muscle Responsiveness. Clin Exp Hypertens A 1991; 13: 277-296.
5. Lohn M, Dubrovska G, Lauterbach B, et al. Periadventitial Fat Releases a Vascular Relaxing Factor. Faseb J 2002; 16: 1057-1063.
6. Fesus G, Dubrovska G, Gorzelniak K, et al. Adiponectin Is a Novel Humoral Vasodilator. Cardiovasc Res 2007; 75: 719-727.
7. Gao YJ, Lu C, Su LY, et al. Modulation of Vascular Function by Perivascular Adipose Tissue: The Role of Endothelium and Hydrogen Peroxide. Br J Pharmacol 2007; 151: 323-331.
8. Gao YJ, Takemori K, Su LY, et al. Perivascular Adipose Tissue Promotes Vasoconstriction: The Role of Superoxide Anion. Cardiovasc Res 2006; 71: 363-373.
9. Pan W, Kastin AJ. Adipokines and the Blood-Brain Barrier. Peptides 2007; 28: 1317-1330.
10. Morris MJ, Velkoska E, Cole TJ. Central and Peripheral Contributions to Obesity-Associated Hypertension: Impact of Early Overnourishment. Exp Physiol 2005; 90: 697-702.
11. Konturek SJ, Konturek PC, Brzozowski T. Melatonin in Gastroprotection against Stress-Induced Acute Gastric Lesions and in Healing of Chronic Gastric Ulcers. J Physiol Pharmacol 2006; 57 Suppl 5: 51-66.
12. Korczynski W, Ceregrzyn M, Matyjek R, et al. Central and Local (Enteric) Action of Orexins. J Physiol Pharmacol 2006; 57 Suppl 6: 17-42.
13. Sobocki J, Krolczyk G, Herman RM, et al. Influence of Vagal Nerve Stimulation on Food Intake and Body Weight - Results of Experimental Studies. J Physiol Pharmacol 2005; 56 Suppl 6: 27-33.
14. Konturek PC, Brzozowski T, Burnat G, et al. Role of Brain-Gut Axis in Healing of Gastric Ulcers. J Physiol Pharmacol 2004; 55(1 Pt 2): 179-192.
15. Takemori K, Gao YJ, Ding L, et al. Elevated Blood Pressure in Transgenic Lipoatrophic Mice and Altered Vascular Function. Hypertension 2007; 49: 365-372.
16. Lafontan M, Berlan M. Fat Cell Adrenergic Receptors and the Control of White and Brown Fat Cell Function. J Lipid Res 1993; 34: 1057-1091.
17. Mercer JG, Hoggard N, Williams LM, et al. Localization of Leptin Receptor Mrna and the Long Form Splice Variant (Ob-Rb) in Mouse Hypothalamus and Adjacent Brain Regions by in Situ Hybridization. FEBS Lett 1996; 387: 113-116.
18. Kaminski T, Smolinska N, Gajewska A, et al. Leptin and Long Form of Leptin Receptor Genes Expression in the Hypothalamus and Pituitary During the Luteal Phase and Early Pregnancy in Pigs. J Physiol Pharmacol 2006; 57: 95-108.
19. Kosior-Korzecka U, Bobowiec R. Leptin Effect on Nitric Oxide and Gnrh-Induced Fsh Secretion from Ovine Pituitary Cells in Vitro. J Physiol Pharmacol 2006; 57: 637-647.
20. Bogacka I, Przala J, Siawrys G, et al. The Expression of Short from of Leptin Receptor Gene During Early Pregnancy in the Pig Examined by Quantitative Real Time Rt-Pcr. J Physiol Pharmacol 2006; 57: 479-489.
21. Winters B, Mo Z, Brooks-Asplund E, et al. Reduction of Obesity, as Induced by Leptin, Reverses Endothelial Dysfunction in Obese (Lep(Ob)) Mice. J Appl Physiol 2000; 89: 2382-2390.
22. Cattaruzza M, Guzik TJ, Slodowski W, et al. Shear Stress Insensitivity of Endothelial Nitric Oxide Synthase Expression as a Genetic Risk Factor for Coronary Heart Disease. Circ Res 2004; 95: 841-847.
23. Guzik TJ, Black E, West NE, et al. Relationship between the G894t Polymorphism (Glu298asp Variant) in Endothelial Nitric Oxide Synthase and Nitric Oxide-Mediated Endothelial Function in Human Atherosclerosis. Am J Med Genet 2001; 100: 130-137.
24. Guzik TJ, West NE, Black E, et al. Functional Effect of the C242t Polymorphism in the Nad(P)H Oxidase P22phox Gene on Vascular Superoxide Production in Atherosclerosis. Circulation 2000; 102: 1744-1747.
25. Wasik M, Gorska E, Popko K, et al. The Gln223arg Polymorphism of the Leptin Receptor Gene and Peripheral Blood/Bone Marrow Leptin Level in Leukemic Children. J Physiol Pharmacol 2006; 57 Suppl 4: 375-383.
26. Liu MY, Xydakis AM, Hoogeveen RC, et al. Multiplexed Analysis of Biomarkers Related to Obesity and the Metabolic Syndrome in Human Plasma, Using the Luminex-100 System. Clin Chem 2005; 51: 1102-1109.
27. Barouch LA, Berkowitz DE, Harrison RW, et al. Disruption of Leptin Signaling Contributes to Cardiac Hypertrophy Independently of Body Weight in Mice. Circulation 2003; 108: 754-759.
28. Guzik TJ, Olszanecki R, Sadowski J, et al. Superoxide Dismutase Activity and Expression in Human Venous and Arterial Bypass Graft Vessels. J Physiol Pharmacol 2005; 56: 313-323.
29. Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation. J Biol Chem 2002; 277: 25863-25866.
30. Okamoto Y, Kihara S, Ouchi N, et al. Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice. Circulation 2002; 106: 2767-2770.
31. Maeda N, Shimomura I, Kishida K, et al. Diet-Induced Insulin Resistance in Mice Lacking Adiponectin/Acrp30. Nat Med 2002; 8: 731-737.
32. Nishimura K, Setoyama T, Tsumagari H, et al. Endogenous Prostaglandins E(2) and F(2(Alpha)) Serve as an Anti-Apoptotic Factor against Apoptosis Induced by Tumor Necrosis Factor-Alpha in Mouse 3t3-L1 Preadipocytes. Biosci Biotechnol Biochem 2006; 70: 2145-2153.
33. Behre CJ, Fagerberg B, Hulten LM, et al. The Reciprocal Association of Adipocytokines with Insulin Resistance and C-Reactive Protein in Clinically Healthy Men. Metabolism 2005; 54: 439-444.
34. Yamamoto Y, Hirose H, Saito I, et al. Correlation of the Adipocyte-Derived Protein Adiponectin with Insulin Resistance Index and Serum High-Density Lipoprotein-Cholesterol, Independent of Body Mass Index, in the Japanese Population. Clin Sci (Lond) 2002; 103: 137-142.
35. Hirose H, Kawai T, Yamamoto Y, et al. Effects of Pioglitazone on Metabolic Parameters, Body Fat Distribution, and Serum Adiponectin Levels in Japanese Male Patients with Type 2 Diabetes. Metabolism 2002; 51: 314-317.
36. Furukawa S, Fujita T, Shimabukuro M, et al. Increased Oxidative Stress in Obesity and Its Impact on Metabolic Syndrome. J Clin Invest 2004; 114: 1752-1761.
37. Guzik TJ, Adamek-Guzik T, Czerniawska-Mysik A, et al. Nitric Oxide Metabolite Levels in Children and Adult Patients with Atopic Eczema/Dermatitis Syndrome. Allergy 2002; 57: 856.
38. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric Oxide and Superoxide in Inflammation and Immune Regulation. J Physiol Pharmacol 2003; 54: 469-487.
39. Guzik TJ, West NE, Pillai R, et al. Nitric Oxide Modulates Superoxide Release and Peroxynitrite Formation in Human Blood Vessels. Hypertension 2002; 39: 1088-1094.
40. Kawczynska-Drozdz A, Olszanecki R, Jawien J, et al. Ghrelin Inhibits Vascular Superoxide Production in Spontaneously Hypertensive Rats. Am J Hypertens 2006; 19: 764-767.
41. Konturek PC, Konturek JW, Czesnikiewicz-Guzik M, et al. Neuro-Hormonal Control of Food Intake; Basic Mechanisms and Clinical Implications. J Physiol Pharmacol 2005; 56 Suppl 6: 5-25.
42. Malecki MT, Undas A, Cyganek K, et al. Plasma Asymmetric Dimethylarginine (Adma) Is Associated with Retinopathy in Type 2 Diabetes Mellitus. Diabetes Care 2007; 30:2899-2901.
43. Ryszawa N, Kawczynska-Drozdz A, Pryjma J, et al. Effects of Novel Plant Antioxidants on Platelet Superoxide Production and Aggregation in Atherosclerosis. J Physiol Pharmacol 2006; 57: 611-626.
44. Guzik TJ, Harrison DG. Endothelial Nf-Kappab as a Mediator of Kidney Damage: The Missing Link between Systemic Vascular and Renal Disease? Circ Res 2007; 101: 227-229.
45. Park J, Choe SS, Choi AH, et al. Increase in Glucose-6-Phosphate Dehydrogenase in Adipocytes Stimulates Oxidative Stress and Inflammatory Signals. Diabetes 2006; 55: 2939-2949.
46. Flechtner-Mors M, Jenkinson CP, Alt A, et al. Studies of Phosphodiesterase Effects on Adipose Tissue Metabolism in Obese Subjects by the Microdialysis Technique. J Physiol Pharmacol 2005; 56: 355-368.
47. Channon KM, Guzik TJ. Mechanisms of Superoxide Production in Human Blood Vessels: Relationship to Endothelial Dysfunction, Clinical and Genetic Risk Factors. J Physiol Pharmacol 2002; 53: 515-524.
48. Guzik TJ, Harrison DG. Vascular Nadph Oxidases as Drug Targets for Novel Antioxidant Strategies. Drug Discov Today 2006; 11: 524-533.
49. Guzik TJ, Sadowski J, Guzik B, et al. Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease. Arterioscler Thromb Vasc Biol 2006; 26: 333-339.
50. Guzik TJ, Sadowski J, Kapelak B, et al. Systemic Regulation of Vascular Nad(P)H Oxidase Activity and Nox Isoform Expression in Human Arteries and Veins. Arterioscler Thromb Vasc Biol 2004; 24: 1614-1620.
51. Guzik TJ, West NE, Black E, et al. Vascular Superoxide Production by Nad(P)H Oxidase: Association with Endothelial Dysfunction and Clinical Risk Factors. Circ Res 2000; 86: E85-90.
52. Serazin V, Dos Santos E, Morot M, et al. Human Adipose Angiotensinogen Gene Expression and Secretion Are Stimulated by Cyclic Amp Via Increased DNA Cyclic Amp Responsive Element Binding Activity. Endocrine 2004; 25: 97-104.
53. Brucher R, Cifuentes M, Acuna MJ, et al. Larger Anti-Adipogenic Effect of Angiotensin Ii on Omental Preadipose Cells of Obese Humans. Obesity (Silver Spring) 2007; 15: 1643-1646.
54. Bujak-Gizycka B, Madej J, Wolkow PP, et al. Measurement of Angiotensin Metabolites in Organ Bath and Cell Culture Experiments by Liquid Chromatography - Electrospray Ionization - Mass Spectrometry (Lc-Esi-Ms). J Physiol Pharmacol 2007; 58: 529-540.
55. Guzik TJ, Mangalat D, Korbut R. Adipocytokines - Novel Link between Inflammation and Vascular Function? J Physiol Pharmacol 2006; 57: 505-528.
56. Kang SM, Kwon HM, Hong BK, et al. Expression of Leptin Receptor (Ob-R) in Human Atherosclerotic Lesions: Potential Role in Intimal Neovascularization. Yonsei Med J 2000; 41: 68-75.
57. Schafer K, Halle M, Goeschen C, et al. Leptin Promotes Vascular Remodeling and Neointimal Growth in Mice. Arterioscler Thromb Vasc Biol 2004; 24: 112-117.
58. Ramsay JE, Ferrell WR, Crawford L, et al. Divergent Metabolic and Vascular Phenotypes in Pre-Eclampsia and Intrauterine Growth Restriction: Relevance of Adiposity. J Hypertens 2004; 22: 2177-2183.
59. Soderberg S, Ahren B, Jansson JH, et al. Leptin Is Associated with Increased Risk of Myocardial Infarction. J Intern Med 1999; 246: 409-418.
60. Reilly MP, Iqbal N, Schutta M, et al. Plasma Leptin Levels Are Associated with Coronary Atherosclerosis in Type 2 Diabetes. J Clin Endocrinol Metab 2004; 89: 3872-3878.
61. Soderberg S, Stegmayr B, Ahlbeck-Glader C, et al. High Leptin Levels Are Associated with Stroke. Cerebrovasc Dis 2003; 15: 63-69.
62. Dong F, Zhang X, Yang X, et al. Impaired Cardiac Contractile Function in Ventricular Myocytes from Leptin-Deficient Ob/Ob Obese Mice. J Endocrinol 2006; 188: 25-36.
63. Kochan Z, Karbowska J, Swierczynski J. The Effects of Weight Cycling on Serum Leptin Levels and Lipogenic Enzyme Activities in Adipose Tissue. J Physiol Pharmacol 2006; 57 Suppl 6: 115-127.
64. Swierczynski J. Leptin and Age-Related Down-Regulation of Lipogenic Enzymes Genes Expression in Rat White Adipose Tissue. J Physiol Pharmacol 2006; 57 Suppl 6: 85-102.
65. Chorostowska-Wynimko J, Radomska D, Plywaczewski D, et al. Disturbed Angiogenic Activity in Sera from Obstructive Sleep Apnea Patients. J Physiol Pharmacol 2005; 56 Suppl 4: 71-77.
66. Zwirska-Korczala K, Jochem J, Adamczyk-Sowa M, et al. Effect of Extremely Low Frequency of Electromagnetic Fields on Cell Proliferation, Antioxidative Enzyme Activities and Lipid Peroxidation in 3t3-L1 Preadipocytes - an in Vitro Study. J Physiol Pharmacol 2005; 56 Suppl 6: 101-108.
67. Shek EW, Brands MW, Hall JE. Chronic Leptin Infusion Increases Arterial Pressure. Hypertension 1998; 31: 409-414.
68. Knudson JD, Dincer UD, Zhang C, et al. Leptin Receptors Are Expressed in Coronary Arteries, and Hyperleptinemia Causes Significant Coronary Endothelial Dysfunction. Am J Physiol Heart Circ Physiol 2005; 289: H48-56.
69. Anderson CM, Ren J. Leptin, Leptin Resistance and Endothelial Dysfunction in Pre-Eclampsia. Cell Mol Biol (Noisy-le-grand) 2002; 48 Online Pub: OL323-329.
70. Galili O, Versari D, Sattler KJ, et al. Early Experimental Obesity Is Associated with Coronary Endothelial Dysfunction and Oxidative Stress. Am J Physiol Heart Circ Physiol 2007; 292: 904-911.
71. Mussa S, Guzik TJ, Black E, et al. Comparative Efficacies and Durations of Action of Phenoxybenzamine, Verapamil/Nitroglycerin Solution, and Papaverine as Topical Antispasmodics for Radial Artery Coronary Bypass Grafting. J Thorac Cardiovasc Surg 2003; 126: 1798-1805.
72. Black EA, Guzik TJ, West NE, et al. Minimally Invasive Saphenous Vein Harvesting: Effects on Endothelial and Smooth Muscle Function. Ann Thorac Surg 2001; 71: 1503-1507.
73. Guzik TJ, Mussa S, Gastaldi D, et al. Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of Nad(P)H Oxidase and Endothelial Nitric Oxide Synthase. Circulation 2002; 105: 1656-1662.
74. Rahmouni K, Correia ML, Haynes WG, et al. Obesity-Associated Hypertension: New Insights into Mechanisms. Hypertension 2005; 45: 9-14.
75. Dick GM, Katz PS, Farias Iii M, et al. Resistin Impairs Endothelium-Dependent Dilation to Bradykinin, but Not Acetylcholine, in the Coronary Circulation. Am J Physiol Heart Circ Physiol 2006; 291: 2997-3002.
76. Li Y, Wang Y, Li Q, et al. Effect of Resistin on Vascular Endothelium Secretion Dysfunction in Rats. Endothelium 2007; 14: 207-214.
77. Di Simone N, Di Nicuolo F, Sanguinetti M, et al. Resistin Regulates Human Choriocarcinoma Cell Invasive Behaviour and Endothelial Cell Angiogenic Processes. J Endocrinol 2006; 189: 691-699.
78. Mu H, Ohashi R, Yan S, et al. Adipokine Resistin Promotes in Vitro Angiogenesis of Human Endothelial Cells. Cardiovasc Res 2006; 70: 146-157.
79. Takahashi K, Totsune K, Kikuchi K, et al. Expression of Endothelin-1 and Adrenomedullin Was Not Altered by Leptin or Resistin in Bovine Brain Microvascular Endothelial Cells. Hypertens Res 2006; 29: 443-448.
80. Yang RZ, Huang Q, Xu A, et al. Comparative Studies of Resistin Expression and Phylogenomics in Human and Mouse. Biochem Biophys Res Commun 2003; 310: 927-935.
81. Takebayashi K, Suetsugu M, Wakabayashi S, et al. Association between Plasma Visfatin and Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus. Metabolism 2007; 56: 451-458.
82. Guzik TJ, Hoch NE, Brown KA, et al. Role of the T Cell in the Genesis of Angiotensin Ii Induced Hypertension and Vascular Dysfunction. J Exp Med 2007; 204: 2449-2460.
83. Henrichot E, Juge-Aubry CE, Pernin A, et al. Production of Chemokines by Perivascular Adipose Tissue: A Role in the Pathogenesis of Atherosclerosis? Arterioscler Thromb Vasc Biol 2005; 25: 2594-2599.
84. Jankovic BD. Neuro-Immune Network. Basic Structural and Functional Correlates. Acta Neurol (Napoli) 1991; 13: 305-314.
85. Heagy W, Laurance M, Cohen E, et al. Neurohormones Regulate T Cell Function. J Exp Med 1990; 171: 1625-1633.
86. Konturek SJ, Konturek JW, Pawlik T, et al. Brain-Gut Axis and Its Role in the Control of Food Intake. J Physiol Pharmacol 2004; 55(1 Pt 2): 137-154.
87. Shimazu T. Central Nervous System Regulation of Liver and Adipose Tissue Metabolism. Diabetologia 1981; 20 Suppl: 343-356.
88. Antic V, Dulloo A, Montani JP. Multiple Mechanisms Involved in Obesity-Induced Hypertension. Heart Lung Circ 2003; 12: 84-93.
89. Yi CX, van der Vliet J, Dai J, et al. Ventromedial Arcuate Nucleus Communicates Peripheral Metabolic Information to the Suprachiasmatic Nucleus. Endocrinology 2006; 147: 283-294.
90. Cota D, Barrera JG, Seeley RJ. Leptin in Energy Balance and Reward: Two Faces of the Same Coin? Neuron 2006; 51: 678-680.
91. Cota D, Proulx K, Smith KA, et al. Hypothalamic Mtor Signaling Regulates Food Intake. Science 2006; 312: 927-930.
92. Beltowski J. Leptin and Atherosclerosis. Atherosclerosis 2006; 189: 47-60.
93. Beltowski J. Role of Leptin in Blood Pressure Regulation and Arterial Hypertension. J Hypertens 2006; 24: 789-801.
94. Chalmers L, Kaskel FJ, Bamgbola O. The Role of Obesity and Its Bioclinical Correlates in the Progression of Chronic Kidney Disease. Adv Chronic Kidney Dis 2006; 13: 352-364.
95. Knudson JD, Dincer UD, Dick GM, et al. Leptin Resistance Extends to the Coronary Vasculature in Prediabetic Dogs and Provides a Protective Adaptation against Endothelial Dysfunction. Am J Physiol Heart Circ Physiol 2005; 289: H1038-H1046.
96. Tentolouris N, Liatis S, Katsilambros N. Sympathetic System Activity in Obesity and Metabolic Syndrome. Ann N Y Acad Sci 2006; 1083: 129-152.
97. Haynes WG. Interaction between Leptin and Sympathetic Nervous System in Hypertension. Curr Hypertens Rep 2000; 2: 311-318.
98. Hall JE. Pathophysiology of Obesity Hypertension. Curr Hypertens Rep 2000; 2: 139-147.
99. Hall JE, Brands MW, Hildebrandt DA, et al. Role of Sympathetic Nervous System and Neuropeptides in Obesity Hypertension. Braz J Med Biol Res 2000; 33: 605-618.
100. Fliers E, Kreier F, Voshol PJ, et al. White Adipose Tissue: Getting Nervous. J Neuroendocrinol 2003; 15: 1005-1010.
101. Brito MN, Brito NA, Baro DJ, et al. Differential Activation of the Sympathetic Innervation of Adipose Tissues by Melanocortin Receptor Stimulation. Endocrinology 2007; 148: 5339-5347.
102. Bartness TJ, Song CK. Brain-Adipose Tissue Neural Crosstalk. Physiol Behav 2007; 91: 343-351.
103. Vague J, Vague P, Tramoni M, et al. Obesity and Diabetes. Acta Diabetol Lat 1980; 17: 87-99.
104. Krolczyk G, Laskiewicz J, Sobocki J, et al. The Effects of Baclofen on the Feeding Behaviour and Body Weight of Vagally Stimulated Rats. J Physiol Pharmacol 2005; 56: 121-131.